Citations as recorded by:
1. The Emerging Role of Polo-Like Kinase 1 in Epithelial-Mesenchymal Transition and Tumor Metastasis
Cancers, 2017, 9(10) p. 131
DOI: 10.3390/cancers9100131
Citations as recorded by:
2. Towards Prognostic Profiling of Non-Small Cell Lung Cancer: New Perspectives on the Relevance of Polo-Like Kinase 1 Expression, the Mutation Status and Hypoxia
J Cancer, 2017, 8 p. 1441
DOI: 10.7150/jca.18455
Citations as recorded by:
3. The clinical and prognostic value of polo-like kinase 1 in lung squamous cell carcinoma patients: immunohistochemical analysis
Biosci Rep, 2017, 37
DOI: 10.1042/BSR20170852
Citations as recorded by:
4. Prognostic significance of the genetic and the immunohistochemical expression of epithelial-mesenchymal-related markers in colon cancer
CBM, 2017, 20(1) p. 107
DOI: 10.3233/CBM-170034
Citations as recorded by:
5. Spindle Assembly Checkpoint as a Potential Target in Colorectal Cancer: Current Status and Future Perspectives
Clinical Colorectal Cancer, 2017, 16(1) p. 1
DOI: 10.1016/j.clcc.2016.06.006
Citations as recorded by:
6. PLK1, a potential target for cancer therapy
Year: 2017
Citations as recorded by:
7. Plk1 inhibition leads to a failure of mitotic division during the first mitotic division in pig embryos
Year: 2017
Citations as recorded by:
8. PLK1 在非霍奇金淋巴瘤中的研究进展
Year: 2017
Citations as recorded by:
9. Towards Prognostic Profiling of Non-Small Cell Lung Cancer: New Perspectives on the Relevance of Polo-Like Kinase 1 Expression, the TP53 Mutation Status …
Year: 2017
Citations as recorded by:
10. 以 PLK1 PBD 为靶点小分子抑制剂的筛选及抗肿瘤活性研究
Year: 2017
Citations as recorded by:
11. The association of HMGB1 expression with clinicopathological significance and prognosis in Asian patients with colorectal carcinoma: a meta-analysis and literature review
Onco Targets Ther, 2016, 9 p. 4901
DOI: 10.2147/OTT.S105512
Citations as recorded by:
12. PLK1 promotes epithelial-mesenchymal transition and metastasis of gastric carcinoma cells.
Am J Transl Res, 2016, 8 p. 4
Citations as recorded by:
13. Important molecular genetic markers of colorectal cancer
Oncotarget, 2016, 7 p. 53959
DOI: 10.18632/oncotarget.9796
Citations as recorded by:
14. The physical interaction of p53 and plakoglobin is necessary for their synergistic inhibition of migration and invasion
Oncotarget, 2016, 7 p. 26898
DOI: 10.18632/oncotarget.8616
Citations as recorded by:
15. Polo-like kinase 1 induces epithelial-to-mesenchymal transition and promotes epithelial cell motility by activating CRAF/ERK signaling
5
DOI: 10.7554/eLife.10734
Citations as recorded by:
16. Plk2 promotes tumor growth and inhibits apoptosis by targeting Fbxw7/Cyclin E in colorectal cancer
Cancer Letters, 2016, 380(2) p. 457
DOI: 10.1016/j.canlet.2016.07.004
Citations as recorded by:
17. MicroRNA-200b Impacts Breast Cancer Cell Migration and Invasion by Regulating Ezrin-Radixin-Moesin
Med Sci Monit, 2016, 22 p. 1946
DOI: 10.12659/MSM.896551
Citations as recorded by:
18. Cancer TARGETases: DSB repair as a pharmacological target
Pharmacology & Therapeutics, 2016, 161 p. 111
DOI: 10.1016/j.pharmthera.2016.02.007
Citations as recorded by:
19. Colorectal cancer carcinogenesis: a review of mechanisms
Cancer Biol Med, 2016, 13 p. 120
DOI: 10.28092/j.issn.2095-3941.2015.0103
Citations as recorded by:
20. Identification of acylthiourea derivatives as potent Plk1 PBD inhibitors
European Journal of Medicinal Chemistry, 2016, 124 p. 229
DOI: 10.1016/j.ejmech.2016.08.043
Citations as recorded by:
21. FOXM1 participates in PLK1-regulated cell cycle progression in renal cell cancer cells.
Oncol Lett, 2016, 11 p. 2
Citations as recorded by:
22. PLK-1 Expression is Associated with Histopathological Response to Neoadjuvant Therapy of Hepatic Metastasis of Colorectal Carcinoma
Year: 2016
Citations as recorded by:
23. Cross Talk between Wnt/β-Catenin and CIP2A/Plk1 Signaling in Prostate Cancer: Promising Therapeutic Implications
Year: 2016
Citations as recorded by:
24. Plk1 和 Cdk1 在细胞周期和肿瘤中的研究进展
Year: 2016
Citations as recorded by:
25. The association of HMGB1 expression with clinicopathological significance and prognosis in Asian patients with colorectal carcinoma: a meta-analysis and …
Year: 2016
Citations as recorded by:
26. PLK1 和 AuroraA 在消化系统肿瘤中的研究进展
Year: 2016
Citations as recorded by:
27. Polo 样激酶 1 在直肠癌的表达及临床意义
Year: 2016
Citations as recorded by:
28. Phase I trial of volasertib, a Polo-like kinase inhibitor, plus platinum agents in solid tumors: safety, pharmacokinetics and activity
Invest New Drugs, 2015, 33 p. 611
DOI: 10.1007/s10637-015-0223-9
Citations as recorded by:
29. Effect of Proliferator-Activated Receptor-γ Pro12Ala Polymorphism on Colorectal Cancer Risk: A Meta-Analysis
Med Sci Monit, 2015, 21 p. 1611
DOI: 10.12659/MSM.892849
Citations as recorded by:
30. Upregulated Polo-Like Kinase 1 Expression Correlates with Inferior Survival Outcomes in Rectal Cancer
PLoS One, 2015, 10
DOI: 10.1371/journal.pone.0129313
Citations as recorded by:
31. Cyanobacterial sunscreen scytonemin: role in photoprotection and biomedical research
Year: 2015
Citations as recorded by:
32. Molecular targeting of the oncoprotein PLK1 in pediatric acute myeloid leukemia: RO3280, a novel PLK1 inhibitor, induces apoptosis in leukemia cells
Year: 2015
Citations as recorded by:
33. BI 6727 and GSK461364 suppress growth and radiosensitize osteosarcoma cells, but show limited cytotoxic effects when combined with conventional treatments
Year: 2015
Citations as recorded by:
34. PLK1 在肿瘤发生中的研究进展
Year: 2015
Citations as recorded by:
35. Chromophobe renal cell carcinoma with and without sarcomatoid change: a clinicopathological, comparative genomic hybridization, and whole-exome …
Year: 2015
Citations as recorded by:
36. PLK1expression and BI 2536 effects in childhood acute lymphoblastic leukemia
Pediatr Blood Cancer, 2014, 61(7) p. 1227
DOI: 10.1002/pbc.24978
Citations as recorded by:
37. Targeting polo-like kinase 1 by NMS-P937 in osteosarcoma cell lines inhibits tumor cell growth and partially overcomes drug resistance.
Invest New Drugs, 2014, 32 p. 1
DOI: 1
Citations as recorded by:
38. The role of High Mobility Group Box 1 (HMGB1) in colorectal cancer
Med Sci Monit, 2014, 20 p. 530
DOI: 10.12659/MSM.890531
Citations as recorded by:
39. Loss of tight junction proteins (Claudin 1, 4, and 7) correlates with aggressive behavior in colorectal carcinoma
Med Sci Monit, 2014, 20 p. 1255
DOI: 10.12659/MSM.890598
Citations as recorded by:
40. New Type of BACE1 siRNA Delivery to Cells
Med Sci Monit, 2014, 20 p. 2598
DOI: 10.12659/MSM.891219
Citations as recorded by:
41. An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma
Br J Cancer, 2014, 110 p. 510
DOI: 10.1038/bjc.2013.731
Citations as recorded by:
42. A sustainable route to produce the scytonemin precursor using Escherichia coli
Year: 2014
Citations as recorded by:
43. Crosstalk between kinases, phosphatases and miRNAs in cancer
Year: 2014
Citations as recorded by:
44. The cyanobacterial pigments scytonemin and nostodione A-Synthesis, photophysicochemical behavior and biological studies
Year: 2014
Citations as recorded by:
45. Ligand-Based Pharmacophore Modeling, Atom-Based 3D-QSAR and Molecular Docking Studies on Substituted Thiazoles and Thiophenes as Polo-Like Kinase 1 ( …
Year: 2014
Citations as recorded by:
46. 蛋白激酶 Plk1 的促肿瘤作用
Year: 2014
Citations as recorded by:
47. Environmental Exposures, Tumor Heterogeneity, and Colorectal Cancer Outcomes
Year: 2014
Citations as recorded by:
48. MiR-100 对肝癌细胞有丝分裂阻滞及 Polo 样激酶 1 蛋白表达的作用
Year: 2014
Citations as recorded by:
49. Assessing colorectal cancer heterogeneity: one step closer to tailored medicine
Journal of Applied Biomedicine, 2013, 11(3) p. 115
DOI: 10.2478/v10136-012-0035-6
Citations as recorded by:
50. Developments of polo-like kinase 1 (Plk1) inhibitors as anti-cancer agents
Year: 2013
Citations as recorded by:
51. 肝癌细胞微小 RNA-100 对细胞有丝分裂的影响
Year: 2013
Citations as recorded by:
52. PLK1 基因 RNAi 慢病毒载体的构建及对食管鳞癌细胞侵袭转移的影响
Year: 2013
Citations as recorded by:
53. 慢病毒介导的人 PLK1 RNA 干扰对食管鳞癌细胞裸鼠移植瘤的抑制作用及机制
Year: 2013
Citations as recorded by:
54. Effect of microRNA-100 on mitosis in hepatocellular carcinoma cells
Year: 2013
Citations as recorded by:
55. Polo-like kinase 1 as target for cancer therapy
Exp Hematol Oncol, 2012, 1 p. 38
DOI: 10.1186/2162-3619-1-38
Citations as recorded by: